Dr. K. Abedulla Khan

Dr. K. Abedulla Khan (Kayamkani Abedulla Khan) is an Associate Professor with 20 years of experience in pharmaceutical education and clinical pharmacy, specialising in Pharmacotherapy, Pharmacovigilance, Evidence-Based Medicine, and Pharmacoepidemiology & Pharmacoeconomics. His expertise spans clinical trial methodology, drug utilization research, and pharmacovigilance, with 50+ peer-reviewed publications across international journals and 3 granted patents. He has taught Pharm.D. and M.Sc. Clinical Pharmacy students, guided student research projects, and served in clinical pharmacy roles at tertiary-care hospitals in India and Saudi Arabia — including as an OSCE Pharm.D. Coordinator and member of Institutional Ethics Committees. He is a Life Member of the Association of Pharmaceutical Teachers of India (APTI), a registered member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and an ISPOR Latin America Consortium Education Committee Member from India.

• Ph.D. — Andhra University, Visakhapatnam, Andhra Pradesh, India (2008–2012)
  Thesis: Pharmacokinetic and pharmacodynamic interactions of anti-diabetic drugs and antiarrhythmic drugs
• M.Pharm (Pharmacy Practice) — Annamalai University, Tamil Nadu, India (2000–2002)
  Thesis: Development of Standard Treatment Guidelines for the Treatment of Nosocomial Wound Infection in Postoperative Patients
• B.Pharm — Bangalore University, Karnataka, India (1995–1999)

Selected from 50+ peer-reviewed publications; 3 granted patents

• "The Role of Clinical Pharmacists in Optimizing the Rational Use of Multi-Indication Medications: A Narrative Review." Asian Journal of Pharmaceutics, 20(2), Apr–Jun 2026.
• "Advances in Pharmaceutical Care: A Review of Contemporary Developments." Latin American Journal of Pharmacy, 44(2): 87–96, 2025.
• "Pharmacoeconomics of Apixaban against Warfarin — A Review." Journal of Ecophysiology and Occupational Health, 24(3): 229–231, Sep 2024. DOI: 10.18311/jeoh/2024/42000.
• "Assessment of knowledge and attitude regarding self-care among patients undergoing haemodialysis." Medical Science, 27, ms3100, 2023. DOI: 10.54905/disssi/v27i137/e300ms3100.
• "Impact of Antioxidants on the immune system in infectious disease caused by SARS-CoV-2." European Chemical Bulletin, 12(5): 5334–5357, 2023. DOI: 10.31838/ecb/2023.12.5.411.
• "Assessment Of Major Adverse Cardiac Events In Diabetic Patients." Journal of Cardiovascular Disease Research, 14(4), 2023. DOI: 10.31838/jcdr.2023.14.04.259.
• "Antibacterial activity of Illicium verum Essential Oil against MRSA clinical isolates and determination of its phytochemical components." Journal of King Saud University – Science, 34(2), 2022. DOI: 10.1016/j.jksus.2021.101800.
• "A Cross-Section Assessment Study on the Awareness of COVID-19 during the Onset of the Pandemic among the Urban Population of Saudi Arabia." JPRI, 33(51A): 353–361, 2021. DOI: 10.9734/jpri/2021/v33i51A33502.
• "A Study of Prescribing Errors in a Private Tertiary Care Hospital in Saudi Arabia." Journal of Young Pharmacists, 12(4): 55–59, Oct–Dec 2020. DOI: 10.5530/jyp.2020.12.89.
• "Evaluation of drug interactions with medications prescribed to ambulatory patients with metabolic syndrome in the urban area." Advanced Materials Letters, 11(3), 2020. DOI: 10.5185/amlett.2020.031487.
• "Evaluation of drug-utilization patterns based on WHO drug use indicators at outpatient clinics." Advanced Materials Letters, 11(3), 2020. DOI: 10.5185/amlett.2020.031489.
• "Molecular docking and preclinical studies of Gymnema Sylvestre on endothelial nitric oxide synthase (eNOS) in type-2 diabetes-related complications." Journal of Young Pharmacists, 6(4): 25–32, 2014. DOI: 10.5530/jyp.2014.4.5.
• "The mechanism of drug interactions of a selected antiarrhythmic drug with metformin in different animal models." Brazilian Journal of Pharmaceutical Sciences, 53(4): e00054, Dec 2017. DOI: 10.1590/s2175-97902017000400054.
• "Drug Utilization Study In Pediatric Outpatients At OPD Clinics In South Indian Metropolitan City." Indo-American Journal of Pharmaceutical Research, 6(4), Apr 2016. DOI: 10.1044/1980-iajpr.160345.
• "Pharmacodynamic drug interaction of mexiletine with metformin in rats." Research Journal of Pharmaceutical, Biological and Chemical Sciences, 3: 905–911, 2012.
• Patents: Indian Patent No. 379828 — HPLC Method for Analyzing Metformin (granted 22/10/2021, 20-year term); Australian Patent No. 2021104766 — A Vibro-thermal glove for paralyzed patients (granted 19 Jan 2022); Indian Patent Application No. 202121026706 — A machine learning system for predicting cancer (published 16/07/2021).

• Pharmaceutical Care & Pharmacoepidemiology
• Pharmacoeconomics & Health Technology Assessment
• Pharmacovigilance & Medication Error Surveillance
• Drug Utilization Review & Health Informatics
• Clinical Trials & Preclinical Studies (in vitro & in vivo)
• Pharmacy Education & Social Pharmacy